Catalyst
Slingshot members are tracking this event:
FibroGen (FGEN) FG-3019 expect to launch results of 067 Phase 2 study on Idiopathic Pulmonary Fibrosis in third quarter of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FGEN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 07, 2017
Occurred Source:
http://investor.fibrogen.com/phoenix.zhtml?c=253783&p=irol-newsArticle&ID=2292360
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
067 Study, Idiopathic Pulmonary Fibrosis, Fg-3019
